Literature DB >> 30089248

RETRACTED: Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway.

Bole Cao1, Cuixia Liu2, Guifeng Yang2.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Panels from Figure 2C appear similar to panels from Figure 2D of the article that Zhang M., Gao C., Yang Y., Li G., Dong J., Ai Y., Ma Q. and Li W. have published in Cellular Physiology and Biochemistry 42 (2017) 211-221 https://doi.org/10.1159/000477314. Regions of panels ‘Control’ and ‘si-ADAMTS9-AS2’ from Figure 3B appear similar to regions of panels ‘Control’ and ‘si-ADAMTS9-AS2’ from Figure 6C. Regions of panel ‘si-ADAMTS9-AS2’ from Figure 3D appear similar to regions of panel ‘pc-CSTB+si-CSTB’ from Figure 3B of the article that Jian Zhang, ZhenFeng Shi, JinXing Huang and XiaoGuang Zou have published in Oncology Research 24 (2016) 487–494 http://dx.doi.org/10.3727/096504016X14685034103752. Panel ‘Control’ from Figure 4B appears similar to panel ‘pc-CSTB+si-CSTB’ from Figure 4B of the article published by Oncology Research 24 (2016) 487. Regions of panels from Figure 6B appear similar to each other, as well as to regions of panels from Figure 2 of the article that Xiantao Sun, Yang Bai, Chao Yang, Shengyun Hu, Zhili Hou and Guixian Wang have published in Artificial Cells, Nanomedicine, and Biotechnology 47 (2019) 2536-2544 https://doi.org/10.1080/21691401.2019.1621328. Regions of panels from Figure 6D appear similar to each other, as well as to regions of ‘Hypoxia’ panel from Figure 1B of the article that Fei Kong, Juan Jin, Xiaolin Lv, Yubo Han, Xue Liang, Yanyu Gao and Xinglin Duan have published in Biomedicine & Pharmacotherapy 109 (2019) 716-725 https://doi.org/10.1016/j.biopha.2018.10.079. Although this article was published earlier than some of the other articles, the Editor decided to retract this article given concerns about the reliability of the data. Also, the corresponding author has not responded to the journal request to comment on the complaints and to provide the raw data of the results presented by the article.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Cell apoptosis; Cell migration and invasion; Cell proliferation; Gastric cancer; PI3K/Akt pathway; lncRNA ADAMTS9-AS2

Mesh:

Substances:

Year:  2018        PMID: 30089248     DOI: 10.1016/j.biopha.2018.06.146

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  22 in total

Review 1.  The regulatory roles and potential prognosis implications of long non-coding RNAs in gastric cancer.

Authors:  Yue Wang; Fan Yang; Qing Yang
Journal:  Histol Histopathol       Date:  2019-12-03       Impact factor: 2.303

2.  [Recombinant methioninase regulates PI3K/Akt/Glut-1 pathway and inhibits aerobic glycolysis to promote apoptosis of gastric cancer cells].

Authors:  Liqiang Zhou; Shihao Li; Li Liu; Qi Zhou; Yiwu Yuan; Lin Xin
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

3.  Bioinformatic and integrated analysis identifies an lncRNA-miRNA-mRNA interaction mechanism in gastric adenocarcinoma.

Authors:  Yong Liao; Wen Cao; Kunpeng Zhang; Yang Zhou; Xin Xu; Xiaoling Zhao; Xu Yang; Jitao Wang; Shouwen Zhao; Shiyu Zhang; Longfei Yang; Dengxiang Liu; Yanpeng Tian; Weizhong Wu
Journal:  Genes Genomics       Date:  2021-03-29       Impact factor: 1.839

4.  LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis.

Authors:  Jiewen Su; Dawei Chen; Yi Ruan; Yuan Tian; Kaiji Lv; Xinhua Zhou; Dongjian Ying; Yeting Lu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

5.  Long noncoding RNA STXBP5-AS1 inhibits cell proliferation, migration, and invasion through inhibiting the PI3K/AKT signaling pathway in gastric cancer cells.

Authors:  Dongzhi Cen; Hu Huang; Liu Yang; Kai Guo; Jinshan Zhang
Journal:  Onco Targets Ther       Date:  2019-03-08       Impact factor: 4.147

6.  Construction of a Competitive Endogenous RNA Network and Identification of Potential Regulatory Axis in Gastric Cancer.

Authors:  Hongda Pan; Chunmiao Guo; Jingxin Pan; Dongwei Guo; Shibo Song; Ye Zhou; Dazhi Xu
Journal:  Front Oncol       Date:  2019-10-04       Impact factor: 6.244

7.  Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.

Authors:  Hongda Pan; Jingxin Pan; Shibo Song; Lei Ji; Hong Lv; Zhangru Yang
Journal:  J Cell Mol Med       Date:  2019-05-29       Impact factor: 5.310

8.  LncRNA ADAMTS9-AS2 suppresses the proliferation of gastric cancer cells and the tumorigenicity of cancer stem cells through regulating SPOP.

Authors:  Feiran Wang; Chong Tang; Dong Xu; Yijie Tang; Yasu Jiang; Xuesong Gao; Junfei Xu
Journal:  J Cell Mol Med       Date:  2020-03-11       Impact factor: 5.310

9.  LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.

Authors:  Niansheng Ren; Tao Jiang; Chengbo Wang; Shilin Xie; Yanwei Xing; Daxun Piao; Tiemin Zhang; Yuekun Zhu
Journal:  Aging (Albany NY)       Date:  2020-06-09       Impact factor: 5.682

10.  The lncRNA ADAMTS9-AS2 Regulates RPL22 to Modulate TNBC Progression via Controlling the TGF-β Signaling Pathway.

Authors:  Kan Ni; Zhiqi Huang; Yichun Zhu; Dandan Xue; Qin Jin; Chunhui Zhang; Changjiang Gu
Journal:  Front Oncol       Date:  2021-06-09       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.